Latest filing published 18 Jun 2025 for BioAtla, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -74.8%Entry US$100.00 · Close at T+365 US$25.25
- -79.9%Entry US$159.00 · Close at T+365 US$32.00
- -12.1%Entry US$103.00 · Close at T+365 US$90.50
- -75.8%Entry US$417.00 · Close at T+365 US$101.00
- -84.0%Entry US$496.50 · Close at T+365 US$79.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Sylvia Mcbrinn: trading record in brief
All filings by Sylvia Mcbrinn on record concern BioAtla, Inc. Over a trading history stretching from 12 September 2022 to 18 June 2025, the count stands at 9 filings.
The open-market record is one-sided, with 7 purchases worth €93k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants.
In size, the median ticket on the buying side is €8,672. Clusters matter here: 2 out of 7 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Looking at 6 purchases old enough to measure, the stock rose over the following 90 days in 50% of cases; the median change was -1.2%. This is a record of the past, not a forecast.
Most recently, on 18 June 2025, the filings show a share grant in BioAtla, Inc. The last purchase on record was published on 19 January 2024, which is 1,026 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sylvia Mcbrinn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 23,500 shares0Common StockSEC:0000950170-25-088061:0
- 16,500 shares0Common StockSEC:0000950170-24-073681:0
- 4,000 shares@ US$2.3510.3% of flowCommon StockSEC:0001209191-24-001929:0Canonical exit: 26 Jun 2023 (T+90)
- 4,000 shares@ US$2.3310.0% of flowCommon StockSEC:0001209191-23-059720:0Canonical exit: 25 Mar 2024 (T+90)
- 2,000 shares@ US$2.545.6% of flowCommon StockSEC:0001209191-23-049347:0Canonical exit: 7 Dec 2023 (T+90)
- 3,700 shares@ US$8.327934.4% of flowCommon StockSEC:0001209191-22-062000:0Canonical exit: 19 Mar 2023 (T+90)
- 2,000 shares@ US$8.269819.1% of flowCommon StockSEC:0001209191-22-058723:0Canonical exit: 20 Feb 2023 (T+90)
- 2,000 shares@ US$8.8520.7% of flowCommon StockSEC:0001209191-22-050147:0Canonical exit: 11 Dec 2022 (T+90)
8 of 8 declarations